World Solve — A living repository of problems worth solving.

What World Solve is

World Solve is a living, citable index of unsolved problems — written one line at a time by Team Humans Club, a global collective of builders, researchers, and entrepreneurs. We do not solve the problems here. We Democratize Innovation.

For builders Skip the search for a problem worth your time. Browse a vetted, growing list and start where the gap is real.

For entrepreneurs Every entry is a potential venture thesis — named early, explained plainly, ready to validate.

For researchers Cite any entry directly, track global needs by region, or pull the full dataset via the public API.

2165 total logged

2165 still open

0 marked solved

8 registered profiles

Precision medicine will create new inequalities if access remains limited. This variant focuses on data infrastructure and measurement challenges over the next two decades.

open Global / Unspecified, Global

Genomic and biomarker-driven therapies will transform oncology and rare disease care, but high costs and limited capacity risk concentrating benefits in wealthy populations. Fair pricing, global data-sharing, and low-cost diagnostics will be critical.

will limited data precision medicine health-biology

WS02031 · Logged by Ian Patel on 2026-07-22T20:40:00Z · Horizon: 10-20 years · Working on: 0

Citation ID: WS02031 Title: Precision medicine will create new inequalities if access remains limited. This variant focuses on data infrastructure and measurement challenges over the next two decades. URL: https://www.worldsolve.org/index.php?api=problem&id=2031